Impact of the Platelet-to-Lymphocyte Ratio as a Biomarker for Esophageal Squamous Cell Carcinoma

被引:8
作者
Kato, Takashi [1 ]
Oshikiri, Taro [1 ]
Goto, Hironobu [1 ]
Sawada, Ryuichiro [1 ]
Harada, Hitoshi [1 ]
Urakawa, Naoki [1 ]
Hasegawa, Hiroshi [1 ]
Kanaji, Shingo [1 ]
Yamashita, Kimihiro [1 ]
Matsuda, Takeru [2 ]
Kakeji, Yoshihiro [1 ]
机构
[1] Kobe Univ, Grad Sch Med, Dept Surg, Div Gastrointestinal Surg, Kobe, Hyogo, Japan
[2] Kobe Univ, Grad Sch Med, Dept Surg, Div Minimally Invas Surg, Kobe, Hyogo, Japan
关键词
Biomarker; esophageal squamous cell carcinoma; platelet-to-lymphocyte ratio; RECURRENT LARYNGEAL NERVE; CHARACTERISTIC ROC CURVE; LAPAROSCOPIC SURGERY; CANCER; LYMPHADENECTOMY; INFLAMMATION; LEUKOCYTE; SURVIVAL; OUTCOMES;
D O I
10.21873/anticanres.15757
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background/Aim: Esophageal squamous cell carcinoma (ESCC) is a deadly malignant disease. This study examined whether the platelet-to-lymphocyte ratio (PLR) can be used as a biomarker to evaluate prognosis in patients with advanced ESCC following neoadjuvant chemotherapy (NAC) and undergoing minimally invasive esophagectomy (MIE). Patients and Methods: We examined 174 patients between January 2010 and December 2015 at the Kobe University. Of these, 121 were treated with NAC. The PLR cutoff was determined through receiver-operating characteristic curve analysis. Univariate and multivariate analyses were conducted to identify prognostic factors for overall survival (OS). Results: The PLR cutoff for OS in 121 patients was 169.6. Patients with PLR 169.6 (61.1%, p=0.001). Multivariate analysis revealed that a PLR of 169.6 was an independent factor for poor prognosis. Conclusion: PLR is an independent prognostic factor for patients with ESCC after NAC and MIE.
引用
收藏
页码:2775 / 2782
页数:8
相关论文
共 50 条
  • [31] Preoperative platelet-to-lymphocyte ratio is a predictor of prognosis in patients with ampullary carcinoma
    Demirci, N. S.
    Ozdemir, N. Y.
    Erdem, G. U.
    Bozkaya, Y.
    Yazici, O.
    Zengin, N.
    BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY, 2018, 119 (03): : 180 - 186
  • [32] Postoperative neutrophil-to-lymphocyte ratio plus platelet-to-lymphocyte ratio predicts the outcomes of hepatocellular carcinoma
    Li, Chuan
    Wen, Tian-Fu
    Yan, Lu-Nan
    Li, Bo
    Wang, Wen-Tao
    Yang, Jia-Yin
    Xu, Ming-Qing
    JOURNAL OF SURGICAL RESEARCH, 2015, 198 (01) : 73 - 79
  • [33] Preoperative platelet-to-lymphocyte ratio is a valuable prognostic biomarker in patients with hepatocellular carcinoma undergoing curative liver resection
    Yang, Hao-Jie
    Jiang, Jing-Hang
    Liu, Qing-An
    Zhou, Cheng-Mao
    Du, Yang-feng
    Wu, Tao
    Chen, Neng-Zhi
    Xiang, Bang-De
    TUMOR BIOLOGY, 2017, 39 (06)
  • [34] Platelet-to-lymphocyte ratio as a potential prognostic factor in nasopharyngeal carcinoma A meta-analysis
    Cen, Rui-Xiang
    Li, Yu-Gang
    MEDICINE, 2019, 98 (38)
  • [35] Prognostic significance of platelet-to-lymphocyte ratio in patients with nasopharyngeal carcinoma: a meta-analysis
    Zhang, Junkai
    Feng, Weineng
    Ye, Zhihua
    Wei, Ying
    Li, Lamei
    Yang, Yingyu
    FUTURE ONCOLOGY, 2020, 16 (05) : 117 - 127
  • [36] Platelet-to-Lymphocyte Ratio and Neutrophil-to-Lymphocyte Ratio Are Not Prognostic Biomarkers in Rectal Cancer Patients with Curative Resection
    Portale, Giuseppe
    Cavallin, Francesco
    Valdegamberi, Alessandro
    Frigo, Flavio
    Fiscon, Valentino
    JOURNAL OF GASTROINTESTINAL SURGERY, 2018, 22 (09) : 1611 - 1618
  • [37] The preoperative hemoglobin, albumin, lymphocyte and platelet (HALP) score is a useful predictor in patients with resectable esophageal squamous cell carcinoma
    Feng, Ji-Feng
    Wang, Liang
    Yang, Xun
    BOSNIAN JOURNAL OF BASIC MEDICAL SCIENCES, 2021, 21 (06) : 772 - 780
  • [38] Prognostic value of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in gastric cancer
    Zhang, Yan
    Lu, Jing-Jing
    Du, Yi-Ping
    Feng, Chun-Xia
    Wang, Li-Qiang
    Chen, Min-Bin
    MEDICINE, 2018, 97 (12)
  • [39] Prognostic value of the neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio and systemic immune-inflammation index in patients with laryngeal squamous cell carcinoma
    Li, Zhilin
    Qu, Yi
    Yang, Yang
    An, Wei
    Li, Shaoqing
    Wang, Bin
    He, Ying
    Li, Jing
    Shao, Qi
    Qin, Lizheng
    CLINICAL OTOLARYNGOLOGY, 2021, 46 (02) : 395 - 405
  • [40] Preoperative platelet lymphocyte ratio (PLR) is superior to neutrophil lymphocyte ratio (NLR) as a predictive factor in patients with esophageal squamous cell carcinoma
    Ji-Feng Feng
    Ying Huang
    Qi-Xun Chen
    World Journal of Surgical Oncology, 12